Nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic Breast cancer: Results from the tnAcity trial
- Yardley, D.A.
- Coleman, R.
- Conte, P.
- Cortes, J.
- Brufsky, A.
- Shtivelband, M.
- Young, R.
- Bengala, C.
- Ali, H.
- Eakel, J.
- Schneeweiss, A.
- De La Cruz-Merino, L.
- Wilks, S.
- O’Shaughnessy, J.
- Glück, S.
- Li, H.
- Miller, J.
- Barton, D.
- Harbeck, N.
ISSN: 1569-8041, 0923-7534
Ano de publicación: 2018
Volume: 29
Número: 8
Páxinas: 1763-1770
Tipo: Artigo